Source Name	Characteristics[organism]	Characteristics[organism part]	Characteristics[age]	Characteristics[developmental stage]	Characteristics[cell line]	Characteristics[cell type]	Characteristics[ancestry category]	Characteristics[sex]	Characteristics[disease]	Characteristics[individual]	assay name	Technology Type	comment[label]	comment[file uri]	comment[instrument]	comment[fractionation method]	comment[fraction identifier]	comment[separation]	comment[dissociation method]	comment[collision energy]	comment[cleavage agent details]	comment[modification parameters]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	comment[data file]	Material Type	factor value[organism part]
Sample 1	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC5	run 1	proteomic profiling by mass spectrometer	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110715_EXQ2_TaGe_SA_PC5_1.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	1	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110715_EXQ2_TaGe_SA_PC5_1.raw	tissue	prostate tumors tissue
Sample 1	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC5	run 2	proteomic profiling by mass spectrometer	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110715_EXQ2_TaGe_SA_PC5_2.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	2	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110715_EXQ2_TaGe_SA_PC5_2.raw	tissue	prostate tumors tissue
Sample 1	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC5	run 3	proteomic profiling by mass spectrometer	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110715_EXQ2_TaGe_SA_PC5_3.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	3	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110715_EXQ2_TaGe_SA_PC5_3.raw	tissue	prostate tumors tissue
Sample 1	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC5	run 4	proteomic profiling by mass spectrometer	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110715_EXQ2_TaGe_SA_PC5_4.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	4	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110715_EXQ2_TaGe_SA_PC5_4.raw	tissue	prostate tumors tissue
Sample 1	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC5	run 5	proteomic profiling by mass spectrometer	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110715_EXQ2_TaGe_SA_PC5_5.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	5	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110715_EXQ2_TaGe_SA_PC5_5.raw	tissue	prostate tumors tissue
Sample 1	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC5	run 6	proteomic profiling by mass spectrometer	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110715_EXQ2_TaGe_SA_PC5_6.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	6	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110715_EXQ2_TaGe_SA_PC5_6.raw	tissue	prostate tumors tissue
Sample 2	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC6	run 7	proteomic profiling by mass spectrometer	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110715_EXQ2_TaGe_SA_PC6_1.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	1	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110715_EXQ2_TaGe_SA_PC6_1.raw	tissue	prostate tumors tissue
Sample 2	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC6	run 8	proteomic profiling by mass spectrometer	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110715_EXQ2_TaGe_SA_PC6_2.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	2	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110715_EXQ2_TaGe_SA_PC6_2.raw	tissue	prostate tumors tissue
Sample 2	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC6	run 9	proteomic profiling by mass spectrometer	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110715_EXQ2_TaGe_SA_PC6_3.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	3	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110715_EXQ2_TaGe_SA_PC6_3.raw	tissue	prostate tumors tissue
Sample 2	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC6	run 10	proteomic profiling by mass spectrometer	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110715_EXQ2_TaGe_SA_PC6_4.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	4	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110715_EXQ2_TaGe_SA_PC6_4.raw	tissue	prostate tumors tissue
Sample 2	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC6	run 11	proteomic profiling by mass spectrometer	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110715_EXQ2_TaGe_SA_PC6_5.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	5	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110715_EXQ2_TaGe_SA_PC6_5.raw	tissue	prostate tumors tissue
Sample 2	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC6	run 12	proteomic profiling by mass spectrometer	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110715_EXQ2_TaGe_SA_PC6_6.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	6	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110715_EXQ2_TaGe_SA_PC6_6.raw	tissue	prostate tumors tissue
Sample 3	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC23	run 13	proteomic profiling by mass spectrometer	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110729_EXQ3_TaGe_SA_PC23_1_110730171023.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	1	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110729_EXQ3_TaGe_SA_PC23_1_110730171023.raw	tissue	prostate tumors tissue
Sample 3	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC23	run 14	proteomic profiling by mass spectrometer	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110729_EXQ3_TaGe_SA_PS23_2_110730211136.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	2	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110729_EXQ3_TaGe_SA_PS23_2_110730211136.raw	tissue	prostate tumors tissue
Sample 3	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC23	run 15	proteomic profiling by mass spectrometer	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110729_EXQ3_TaGe_SA_PS23_3.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	3	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110729_EXQ3_TaGe_SA_PS23_3.raw	tissue	prostate tumors tissue
Sample 3	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC23	run 16	proteomic profiling by mass spectrometer	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110729_EXQ3_TaGe_SA_PS23_4.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	4	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110729_EXQ3_TaGe_SA_PS23_4.raw	tissue	prostate tumors tissue
Sample 3	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC23	run 17	proteomic profiling by mass spectrometer	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110729_EXQ3_TaGe_SA_PS23_5.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	5	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110729_EXQ3_TaGe_SA_PS23_5.raw	tissue	prostate tumors tissue
Sample 3	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC23	run 18	proteomic profiling by mass spectrometer	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110729_EXQ3_TaGe_SA_PS23_6.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	6	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110729_EXQ3_TaGe_SA_PS23_6.raw	tissue	prostate tumors tissue
Sample 4	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC24	run 19	proteomic profiling by mass spectrometer	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110729_EXQ3_TaGe_SA_PC24_1.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	1	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110729_EXQ3_TaGe_SA_PC24_1.raw	tissue	prostate tumors tissue
Sample 4	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC24	run 20	proteomic profiling by mass spectrometer	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110729_EXQ3_TaGe_SA_PC24_2.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	2	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110729_EXQ3_TaGe_SA_PC24_2.raw	tissue	prostate tumors tissue
Sample 4	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC24	run 21	proteomic profiling by mass spectrometer	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110729_EXQ3_TaGe_SA_PC24_3.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	3	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110729_EXQ3_TaGe_SA_PC24_3.raw	tissue	prostate tumors tissue
Sample 4	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC24	run 22	proteomic profiling by mass spectrometer	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110729_EXQ3_TaGe_SA_PC24_4.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	4	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110729_EXQ3_TaGe_SA_PC24_4.raw	tissue	prostate tumors tissue
Sample 4	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC24	run 23	proteomic profiling by mass spectrometer	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110729_EXQ3_TaGe_SA_PC24_5.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	5	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110729_EXQ3_TaGe_SA_PC24_5.raw	tissue	prostate tumors tissue
Sample 4	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC24	run 24	proteomic profiling by mass spectrometer	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110729_EXQ3_TaGe_SA_PC24_6.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	6	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110729_EXQ3_TaGe_SA_PC24_6.raw	tissue	prostate tumors tissue
Sample 5	Homo sapiens	non-malignant prostate tissue	not available	not available	not applicable	not applicable	not available	not available	control	PC25	run 25	proteomic profiling by mass spectrometer	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110729_EXQ3_TaGe_SA_PC25_1.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	1	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110729_EXQ3_TaGe_SA_PC25_1.raw	tissue	non-malignant prostate tissue
Sample 5	Homo sapiens	non-malignant prostate tissue	not available	not available	not applicable	not applicable	not available	not available	control	PC25	run 26	proteomic profiling by mass spectrometer	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110729_EXQ3_TaGe_SA_PC25_2.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	2	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110729_EXQ3_TaGe_SA_PC25_2.raw	tissue	non-malignant prostate tissue
Sample 5	Homo sapiens	non-malignant prostate tissue	not available	not available	not applicable	not applicable	not available	not available	control	PC25	run 27	proteomic profiling by mass spectrometer	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110729_EXQ3_TaGe_SA_PC25_3.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	3	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110729_EXQ3_TaGe_SA_PC25_3.raw	tissue	non-malignant prostate tissue
Sample 5	Homo sapiens	non-malignant prostate tissue	not available	not available	not applicable	not applicable	not available	not available	control	PC25	run 28	proteomic profiling by mass spectrometer	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110729_EXQ3_TaGe_SA_PC25_4.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	4	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110729_EXQ3_TaGe_SA_PC25_4.raw	tissue	non-malignant prostate tissue
Sample 6	Homo sapiens	non-malignant prostate tissue	not available	not available	not applicable	not applicable	not available	not available	control	PC18	run 29	proteomic profiling by mass spectrometer	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110819_EXQ3_TaGe_SA_PC18_1.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	1	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110819_EXQ3_TaGe_SA_PC18_1.raw	tissue	non-malignant prostate tissue
Sample 6	Homo sapiens	non-malignant prostate tissue	not available	not available	not applicable	not applicable	not available	not available	control	PC18	run 30	proteomic profiling by mass spectrometer	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110819_EXQ3_TaGe_SA_PC18_2.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	2	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110819_EXQ3_TaGe_SA_PC18_2.raw	tissue	non-malignant prostate tissue
Sample 6	Homo sapiens	non-malignant prostate tissue	not available	not available	not applicable	not applicable	not available	not available	control	PC18	run 31	proteomic profiling by mass spectrometer	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110819_EXQ3_TaGe_SA_PC18_3.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	3	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110819_EXQ3_TaGe_SA_PC18_3.raw	tissue	non-malignant prostate tissue
Sample 6	Homo sapiens	non-malignant prostate tissue	not available	not available	not applicable	not applicable	not available	not available	control	PC18	run 32	proteomic profiling by mass spectrometer	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110819_EXQ3_TaGe_SA_PC18_4.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	4	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110819_EXQ3_TaGe_SA_PC18_4.raw	tissue	non-malignant prostate tissue
Sample 6	Homo sapiens	non-malignant prostate tissue	not available	not available	not applicable	not applicable	not available	not available	control	PC18	run 33	proteomic profiling by mass spectrometer	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110819_EXQ3_TaGe_SA_PC18_5.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	5	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110819_EXQ3_TaGe_SA_PC18_5.raw	tissue	non-malignant prostate tissue
Sample 6	Homo sapiens	non-malignant prostate tissue	not available	not available	not applicable	not applicable	not available	not available	control	PC18	run 34	proteomic profiling by mass spectrometer	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110819_EXQ3_TaGe_SA_PC18_6.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	6	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110819_EXQ3_TaGe_SA_PC18_6.raw	tissue	non-malignant prostate tissue
Sample 7	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC19	run 35	proteomic profiling by mass spectrometer	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110819_EXQ3_TaGe_SA_PC19_1.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	1	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110819_EXQ3_TaGe_SA_PC19_1.raw	tissue	prostate tumors tissue
Sample 7	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC19	run 36	proteomic profiling by mass spectrometer	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110819_EXQ3_TaGe_SA_PC19_2.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	2	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110819_EXQ3_TaGe_SA_PC19_2.raw	tissue	prostate tumors tissue
Sample 7	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC19	run 37	proteomic profiling by mass spectrometer	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110819_EXQ3_TaGe_SA_PC19_3.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	3	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110819_EXQ3_TaGe_SA_PC19_3.raw	tissue	prostate tumors tissue
Sample 7	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC19	run 38	proteomic profiling by mass spectrometer	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110819_EXQ3_TaGe_SA_PC19_4.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	4	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110819_EXQ3_TaGe_SA_PC19_4.raw	tissue	prostate tumors tissue
Sample 7	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC19	run 39	proteomic profiling by mass spectrometer	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110819_EXQ3_TaGe_SA_PC19_5.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	5	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110819_EXQ3_TaGe_SA_PC19_5.raw	tissue	prostate tumors tissue
Sample 7	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC19	run 40	proteomic profiling by mass spectrometer	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110819_EXQ3_TaGe_SA_PC19_6.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	6	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110819_EXQ3_TaGe_SA_PC19_6.raw	tissue	prostate tumors tissue
